web analytics
logo
logo
  • HOME
  • TECHNOLOGY
    • Technology
    • Publications
    • The G-Rex® Invention Video
    • G-Rex Closed System Video
    • T-Cell Expansion: G-Rex vs Rocking/Motion Bioreactors
    • Future of T Cell Manufacturing Video
  • APPLICATIONS
    • G-Rex for T Cell Therapy
    • Innovations for Routine Cell Culture
  • PRODUCT & ORDER INFO
    • Ordering Info
    • G-Rex Documentation
    • FAQ
  • NEWS
  • ABOUT
  • CONTACT US
  • Featured
  • CAR-T & TCR
  • CTL & VST
  • G-Rex IFU
  • G-Rex Information
  • NK, Treg, HSC & Others
  • TIL
Manufacture of GMP-compliant functional adenovirus-specificT-cell therapy for treatment of post-transplant infectious complications
Authors: CLAIRE HORLOCK, et al
Publication: Cytotherapy
Published Date : 6/1/2016
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application
Authors: Jiali Sun, et al
Publication: Journal of Immunotherapy of Cancer
Published Date : 1/4/2015
Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections After HSCT
Authors: Anastasia Papadopoulou, et al
Publication: Science Translational Medicine
Published Date : 6/25/2014
First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation
Authors: Rene´ Geyeregger, et al
Publication: Journal of Immunotherapy
Published Date : 5/3/2014
Accelerating immune reconstitution after hematopoietic stem cell transplantation
Authors: Ifigeneia Tzannou, et al
Publication: Clinical & Translational Immunology
Published Date : 1/1/2014
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
Authors: Ulrike Gerdemann, et al
Publication: Molecular Therapy
Published Date : 11/1/2013
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Authors: Ann M. Leen, et al
Publication: Blood Journal
Published Date : 6/1/2013
T lymphocytes targeting native receptors
Authors: Cliona Rooney, et al
Publication: Immunological Reviews
Published Date : 1/1/2013
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
Authors: Ulrike Gerdemann, et al
Publication: Molecular Therapy
Published Date : 8/5/2012
Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials
Authors: Cliona Rooney, et al
Publication: Molecular Therapy Nucleic Acids
Published Date : 1/1/2012
OptimizationManufacture of Virus- and Tumor-Specific T Cells
Authors: Natalia Lapteva, et al
Publication: Stem Cells International
Published Date : 6/1/2011
Manufacture of GMP-grade Cytotoxic T Lymphocytes specific for LMP1 and LMP2 for Patients with EBV-associated Lymphoma
Authors: Catherine M. Bollard, et al
Publication: Cytotherapy
Published Date : 5/1/2011
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Authors: Ulrike Gerdemann, et al
Publication: Journal of Visualized Experiements
Published Date : 1/1/2011
Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy
Authors: Cornelis JM Melief, et al
Publication: Journal of Translational Medicine
Published Date : 1/1/2011
Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)
Authors: Juan F. Vera, et al
Publication: Journal of Immunotherapy
Published Date : 4/1/2010
Challenges of T Cell Therapies for Virus-associated Diseases after Hematopoietic Stem Cell Transplantation
Authors: Ann M. Leen, et al
Publication: Expert Opinion on Biological Therapy
Published Date : 3/1/2010
Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes
Authors: Juan F. Vera, et al
Publication: Current Gene Therapy
Published Date : 10/1/2009
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
Authors: Ann M. Leen, et al
Publication: Blood Journal
Published Date : 8/1/2009
  • HOME
    • TECHNOLOGY
    • G-REX APPLICATIONS
    • PRODUCT & ORDER INFO
    • NEWS
    • ABOUT
    • CONTACT US

Contact Us At :

info@wilsonwolf.com
(651) 628-9259
2100 Old Highway 8
Saint Paul, MN 55112

© Copyright Wilson Wolf 2025